Previous Events
Results of Enobia’s ongoing, phase 2 study in juvenile HPP to be presented by Dr. Michael Whyte at the 92nd Annual Endocrine Society Meeting, 11:15am-12:45pm in “Frontiers of Bone & Mineral Biology”
June 20, 2010 | San Diego, CA
More info
Robert Heft, President and CEO to present at 17th Biocentury’s Annual Future Leaders in the Biotech Industry
April 08, 2010 | New York, NY
More info
Robert Heft, President and CEO to present at the BioFinance Conference
April 07, 2010 | Toronoto, Canada
More info
Press Releases
ENB-0040, A Bone Targeted Enzyme Replacement Therapy, Shows Promise in Children with HypophosphatasiaJune 21, 2010Enobia Presents Results from Hypophosphatasia Impact Patient SurveyMarch 29, 2010Enobia Expands Clinical Program for ENB-0040, a Bone-targeted Enzyme Replacement Therapy for HypophosphatasiaNovember 02, 2009
See all Press Releases 
Enobia in the News
Calling Winnipeg, Amy Tinsley, the baby from Northern Ireland who underwent life-saving treatment at Children's Hospital a year ago, says helloFebruary 12, 2010 | Wave MagazineMedical Marvels on Main StreetJanuary 06, 2010 | Bay Cities Mag, Dec/Jan '09 Issue; by Alison FiebigShriners Hospitals for Children's Dr. Michael Whyte Presents First Efficacy and Safety Results of Targeted Enzyme Replacement Therapy in Patients With Rare Genetic Bone DiseaseJune 11, 2009 | Enobia
See all News